LicianPro

CYCN stock

Cyclerion Therapeutics Inc (CYCN) financials · rev $2.1M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cyclerion Therapeutics Inc (CYCN) rev $2.1M.

Annual income statement
LineFY2025FY2024Pro (2 older periods with Lician Pro)
Revenue$2.07M$2.00M
Operating Income−$4.97M−$3.63M
Net Income−$3.53M−$3.06M
EPS (Diluted)−$1.11−$1.21
Unlock 5 years of statements: Lician Pro $149/yr
Annual balance sheet
LineFY2025FY2024Pro (3 older periods with Lician Pro)
Total Assets$9.98M$9.57M
Current Assets$4.63M$4.22M
Cash & Equivalents$3.24M$3.23M
PP&E——
Total Liabilities$900.00K$725.00K
Current Liabilities$900.00K$725.00K
Shareholders' Equity$9.09M$8.85M
Retained Earnings−$271.02M−$267.49M
Annual cash flow
LineFY2025FY2024Pro (3 older periods with Lician Pro)
Operating Cash Flow−$3.31M−$4.33M
Investing Cash Flow——
Financing Cash Flow$3.32M—
Net Change in Cash$8.00K−$4.34M

Source: Company filings with the SEC (EDGAR) · Latest period FY2025

These statements as JSON? API free 100/day

FAQ

What is CYCN P/E and revenue?

Cyclerion Therapeutics Inc (CYCN) rev $2.1M.

What is CYCN revenue?

Cyclerion Therapeutics Inc last cached revenue is $2.07M (FY2025).

Is CYCN profitable?

Cyclerion Therapeutics Inc last cached net income is -$3.53M (FY2025).

What are CYCN total assets?

Cyclerion Therapeutics Inc last cached total assets are $9.98M (FY2025).

What is CYCN free cash flow?

No cached cash-flow row for CYCN yet.

Not investment advice. Figures as reported in company filings, not a live feed.